Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

Related Parents

Related Issuers

PRICED: Almirall E250m 5.5NC2 sr notes 3.75% at 100

HYC European Market: Deal Flow - General

Almirall SA (ALMSM) EUR250m Reg S only sr notes due 06/15/31 (5.5y). NC2 (12/15/27) (MWC B+50bp), then at 101.875 12/15/27, 100.938 12/15/28, 100 12/15/29. Equity claw: 2y 40% at 103.75. Ba2/BB+ (stable/stable). Via BNP/JPM (B&D) jt glocos and physical books/BBVA/BofA/Caixa/Santander jt books. List Lux. NY law. CoC at 101. Pays June 15 and Dec 15, starting 06/15/26. Denoms:100kx1k. Settles 12/17. ISIN: XS3248326533. IPT: low 4s. Price talk: 4% area. Final price talk: 3.75%-3.875%.

Priced: 3.75% at 100. +137bp vs DBR 0.00% 08/15/31.

Roadshow (small group meetings) 12/02-03 (investor call 11am UKT 12/02). Books closed at 1pm UKT 12/03. Reconfirms were due by 2:30pm UKT 12/03. UOP: along with EUR55m  cash on hand, to redeem its EUR300m 2.125% sr notes due 09/30/26 (callable at 100). Biz: a publicly listed global research-focused biopharmaceutical company with a leadership position in Europe, dedicated to Medical Dermatology. HQ: Barcelona, Spain.

Netroadshow direct link: https://www.netroadshow.com/nrs/home/#!/?show=a364261a. Entry code: HEALTH25.


We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.